Although clinically inconsistent, other therapies have reported the beneficial effects of cyclosporin, anti-TNF-α blocking agents, or anti-CD25 mAb in human HLH (Prahalad et al., 2001; Henter et al., 2007; Olin et al., 2008). The gene discussed is TNF; the disease is hemophagocytic syndrome.